Delivery Order SPE2DB20D1109-SPE2DB23FN59M
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Repatha 140 mg/mL syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,016.82 firm-fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities. As the prime contractor, Amerisourcebergen will...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA). The $7,167.57 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick syringes, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,859.27 and an ultimate completion date of August 14, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- This federal contract award is for the delivery of Repatha 140 mg/mL SureClickTM medication to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The $1,016.82 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award, valued at $2,270.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/ml syringes, a specialty medication used for cardiovascular health treatment. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $13,147.05, is for the delivery of Repatha 140 mg/mL syringes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award is for the delivery of Repatha 140 mg/mL SureClick medication to the Defense Logistics Agency (DLA). The $4,081.62 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 10, 2022 with a completion date of January 11, 2022. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award is for the pharmaceutical product Repatha 140 mg/mL syringe. The contract, valued at $18,523.89, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and has an ultimate completion date of February 20, 2025. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen...
- This federal contract award is for the supply of Repatha 140 mg/ml SureClick products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price ceiling value of $3,706.53. The contract has a period of performance through June 5, 2023. The contract is a delivery order awarded under Amerisourcebergen Drug Corp's parent company, Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Repatha, a 140 mg/ml medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on May 10, 2023, with a completion date of May 11, 2023. The contract has a ceiling value of $2,371.96 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN59MDelivery Order
This federal contract award is for the delivery of Repatha 140 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $2,083.88, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 2/22/23 |